Table 2.

Glucose control, HbA1c, insulin delivered during baseline and study phase

	Baseline MDI + CGM, 1 week	Study AHCL, 12 weeks	P
HbA1c, (mmol/mol)	70 ± 18.6	48 ± 7.7	0.001
HbA1c, (%)	8.6 ± 1.7	6.5 ± 0.7	0.001
Sensor glucose (mg/dL)	198 ± 38	138 ± 12	0.001
Percent of sensor glucose values in range
< 54 mg/dL	0.8 ± 0.7	0.5 ± 0.4	0.008
54–70 mg/dL	2.4 ± 2.1	2.3 ± 1.2	0.624
70–180 mg/dL	42.1 ± 18.7	78.8 ± 6.1	0.001
180–250 mg/dL	28.1 ± 9.7	13.4 ± 5.1	0.001
> 250 mg/dL	26.6 ± 16.2	5.0 ± 2.2	0.001
TDD, U/(kg/d)	0.9 ± 0.3	1.1 ± 0.3	0.008
Basal insulin, as % of TDD	38.6 ± 7.5	31.6 ± 6.1	0.001
Weight, kg	48.2 ± 18.5	49.3 ± 17.2	0.800

All values are shown as mean ± SD

MDI Multiple Daily Injections, SG Sensor glucose, TDD Total daily dose of insulin